CRISPR gene therapy: a review
Clinical applicability is limited by issues such off-target effects, PAM sequence restrictions, DNA damage-induced toxicity, and immunological responses to Cas proteins, despite its wide therapeutic potential, but improvements in delivery methods and high-fidelity Cas9 variations are being addressed.
Sanjeyan N., Gobika G., H. S et al.
· International Journal of Bas... · 0 citations